title: Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
abstract: Leukocyte infiltration during acute and chronic inflammation is regulated by exogenous and endogenous factors, including cytokines, chemokines and proteases. Stimulation of fibroblasts and human microvascular endothelial cells with the inflammatory cytokines interleukin-1beta (IL-1beta) or tumour necrosis factor alpha (TNF-alpha) combined with either interferon-alpha (IFN-alpha), IFN-beta or IFN-gamma resulted in a synergistic induction of the CXC chemokine CXCL10, but not of the neutrophil chemoattractant CXCL8. In contrast, simultaneous stimulation with different IFN types did not result in a synergistic CXCL10 protein induction. Purification of natural CXCL10 from the conditioned medium of fibroblasts led to the isolation of CD26/dipeptidyl peptidase IV-processed CXCL10 missing two NH2-terminal residues. In contrast to intact CXCL10, NH2-terminally truncated CXCL10(3-77) did not induce extracellular signal-regulated kinase 1/2 or Akt/protein kinase B phosphorylation in CXC chemokine receptor 3-transfected cells. Together with the expression of CXCL10, the expression of membrane-bound CD26/dipeptidyl peptidase IV was also upregulated in fibroblasts by IFN-gamma, by IFN-gamma plus IL-1beta or by IFN-gamma plus TNF-alpha. This provides a negative feedback for CXCL10-dependent chemotaxis of activated T cells and natural killer cells. Since TNF-alpha and IL-1beta are implicated in arthritis, synovial concentrations of CXCL8 and CXCL10 were compared in patients suffering from crystal arthritis, ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis. All three groups of autoimmune arthritis patients (ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis) had significantly increased synovial CXCL10 levels compared with crystal arthritis patients. In contrast, compared with crystal arthritis, only rheumatoid arthritis patients, and not ankylosing spondylitis or psoriatic arthritis patients, had significantly higher synovial CXCL8 concentrations. Synovial concentrations of the neutrophil chemoattractant CXCL8 may therefore be useful to discriminate between autoimmune arthritis types.
authors.affiliation: Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. paul.proost@rega.kuleuven.be
authors.forename: Paul
authors.initials: P
authors.lastname: Proost
authors.forename: Sofie
authors.initials: S
authors.lastname: Struyf
authors.forename: Tamara
authors.initials: T
authors.lastname: Loos
authors.forename: Mieke
authors.initials: M
authors.lastname: Gouwy
authors.forename: Evemie
authors.initials: E
authors.lastname: Schutyser
authors.forename: René
authors.initials: R
authors.lastname: Conings
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ronsse
authors.forename: Marc
authors.initials: M
authors.lastname: Parmentier
authors.forename: Bernard
authors.initials: B
authors.lastname: Grillet
authors.forename: Ghislain
authors.initials: G
authors.lastname: Opdenakker
authors.forename: Jan
authors.initials: J
authors.lastname: Balzarini
authors.forename: Jo
authors.initials: J
authors.lastname: Van Damme
mesh_terms: D001327:Autoimmune Diseases / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002478:Cells, Cultured; D054357:Chemokine CXCL10; D019743:Chemokines, CXC / Q000737:chemistry / Q000378:metabolism*; D016207:Cytokines / Q000494:pharmacology*; D020405:Dermis / Q000098:blood supply; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004338:Drug Combinations; D042783:Endothelial Cells / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D018836:Inflammation Mediators / Q000494:pharmacology*; D016209:Interleukin-8 / Q000378:metabolism; D007592:Joint Diseases / Q000378:metabolism; D008024:Ligands; D010446:Peptide Fragments / Q000378:metabolism; D020033:Protein Isoforms / Q000378:metabolism; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine / Q000378:metabolism; D012216:Rheumatic Diseases / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D015415:Biomarkers; C114753:CXCL10 protein, human; C515187:CXCR3 protein, human; D054357:Chemokine CXCL10; D019743:Chemokines, CXC; D016207:Cytokines; D004338:Drug Combinations; D018836:Inflammation Mediators; D016209:Interleukin-8; D008024:Ligands; D010446:Peptide Fragments; D020033:Protein Isoforms; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine; D018819:Dipeptidyl Peptidase 4